The Global Summit on Neurodegenerative Diseases NEURO 2020/2022 will take place in the city of Salamanca from June 21 to 24, 2022, under the presidency of H.M. Queen Sofia. This Summit is held within the framework of the event of exceptional interest, "Neurodegenerative Diseases 2020. International Year of Neuro2020 Research and Innovation". That event aims to promote research into neurodegenerative diseases and raise public awareness of the social consequences of these pathologies.
This meeting is annually celebrated under the denomination of International Congress on Innovation and Research in Neurodegenerative Diseases (CiiiEN) and focuses on major research advances in neurodegenerative disorders, particularly Alzheimer's, Parkinson, ALS, and Huntington's diseases. The Congress has been organized since 2013 by the Queen Sofia Foundation, the Center of Research in Neurological Diseases (CIEN) and the Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED). It offers a forum to exchange and discuss a range of areas of interest related to basic, clinical and translational aspects of the research on neurodegenerative diseases. The Summit will focus on scientific research by the CIEN Foundation and CIBERNED. Researchers from several countries will attend this Global Summit. Noteworthy is the participation of 2013 Nobel Prize winner in Medicine, Thomas C. Sudhof (Stanford University, California, USA), among other prestigious researchers.
The University of Salamanca will lend its facilities and services for the proper development of the scientific sessions.The GLOBAL SUMMIT Neuro2020/22 will also collaborate with the City Council of Salamanca, which will provide some resources to the cultural activities associated with the scientific program.
We look forward to welcoming you to Salamanca.
Thomas Sudhof , Stanford University, CA-USA
2013 Nobel Laureate in Physiology or Medicine
"Towards an understanding of Alzheimer’s disease as a synaptic disorder"
Orla Hardiman , Trinity College, Dublin
"The Pathway to Precision Medicine in Amyotrophic Lateral Sclerosis"
Leonard Van den Berg , University of Utrecht
"The road to more effective treatment for amyotrophic lateral sclerosis"
Lu Chen, Stanford University
"The ins and outs of neurexins in homeostatic plasticity and learning"
Rafael Fernández Chacón , Institute of Biomedicine of Seville, CIBERNED
"Homeostatic reprograming of neurons upon presynaptic dysfunction"
Sonia Alonso, Biodonostia Research Institute, CIBERNED
"Intrinsic muscle dysfunction in Amyotrophic Lateral Sclerosis"
Juan Pedro Bolaños, Instituto de Biología Funcional y Genómica. Universidad de Salamanca, CIBERFES
"Metabolic shapes of brain cells and functional consequences"
Oscar Fernández-Capetillo, Spanish National Cancer Research Center
"Mechanisms, mouse models and drug development: A cancer researchers´approach to ALS"
Angeles Almeida, Institute of Biomedical Research, Salamanca
"The p53 Arg72Pro polymorphism determines cognitive decline progression in AD"
José J. Lucas, Center for Molecular Biology Severo Ochoa, CIBERNED
"Altered RNA processing in Huntington’s disease"
Eduardo Tolosa , Clinic Hospital, IDIBAPS, CIBERNED
"Prevention of Parkinson disease: research strategies in the prodromal phase"
David Sulzer , Columbia University, New York
"Autoimmunity in Parkinson’s Disease"
Werner Poewe , University of Innsbruk
"Diagnosing Parkinson's Disease- from the street to the Bench"
José López Barneo, Institute of Biomedicine of Seville, CIBERNED
"Mitochondrial dysfunction and compartmentalized alterations of nigrostriatal dopaminergic neurons in Parkinson disease"
Marcelo Mendonça , Fundação Champalimaud, Lisboa
"Movement and reward modulation in Substantia Nigra pars compacta dopaminergic neurons"
Jaime Kulisevsky, Institut de Recerca Hospital de la Santa Creu i Sant Pau, CIBERNED
"Treatment of Cognitive and Neuropsychiatric impairment in Parkinson’s disease: An unmet need and a methodological challenge"
Inga Zerr, DZNE , University Medical Center Göttingen
"Cerebrospinal fluid and blood based biomarker- recent advances in neurodegenerative diseases"
Teresa Iglesias, Institute of Biomedical Research, CSIC-UAM, CIBERNED
"Molecular targets for Ventriculomegaly and Neurodegeneration"
Joe Paton, Champalimaud Foundation, Lisbon
"Action suppression reveals opponent parallel control of behavior via basal ganglia circuits"
Michel Goedert , MRC Laboratory of Molecular Biology, Cambridge, UK
"Cryo-EM structures of amyloid filaments from human brain"
Kenneth S. Kosik , University of California at Santa Barbara
"A Tangle of Tau Pathways Operate within Cellular Systems"
Luc Buée, Inserm, CHR, Universiy of Lille
"Tau therapeutic strategies"
George Perry, University of Texas at San Antonio
"In search of a cure for Alzheimer disease"
Marta Pascual, University of Barcelona, CIBERNED
"J20/VLW mice as a novel model of cognitive resilience to Alzheimer’s disease"
Bryan Strange, Center for Biomedical Technology UPM, Madrid
"Superaging in Vallecas: Resistance to age-related memory decline"
Bruce Miller, University of California at San Francisco
"Frontotemporal Dementia: Diagnosis to Treatment"
Raquel Sánchez-Valle, Hospital Clinic de Barcelona, IDIBAPS
"Autosomal dominantly inherited dementias: from genetic counselling to early intervention"
Juan Domingo Gispert López , Barcelonabeta Brain Research Center (BBRC)
"Early pathophysiological alterations in Alzheimer's disease: insights from the ALFA cohort"
Alberto Rábano , CIEN Foundation, CIBERNED
"Clinicopathological heterogeneity in Alzheimer’s disease: lessons from the Vallecas Alzheimer’s Study"
Pascual Sánchez-Juan, CIEN Foundation, CIBERNED
"Plasma biomarkers in the Vallecas study. Bridging the gap on the road to the clinic"
Isabel Fariñas , Universitat de València, CIBERNED
"Immune vigilance of adult neural stem cells"
Angel Cedazo-Mínguez , Karolinska Institute
"Danger-associated responses in Alzheimer’s disease brain: Alarmins and Chaperons"
María Llorens-Martín , Center for Molecular Biology, CIBERNED
"Adult hippocampal neurogenesis and neurodegenerative diseases"
The form has been sent successfully.